CYTENA and ExcellGene to develop automated Workflows for biotherapeutics cell line development
CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines
CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines
Particle Works combines a strong heritage in engineering with scientific knowledge, microfluidic expertise and in-house chip fabrication
Data presented at the summit highlighted the potential of Janux’s TRACTr technology platform to support clinical development
Data showing greater glycosylation homogeneity with the FastPharming system compared to traditional methods was presented at PEGS Boston 2022
The acquisition will help Advanced Instruments continue to develop and commercialize leading technologies across the clinical, biopharma, and food and beverage markets
Solution addresses processing quality challenges faced by mid-volume labs
Posters presented at PEGS Boston 2022 highlight how Twist Bioscience’s next-generation libraries enable antibody discovery for a range of therapies
SARS-CoV-2 Saliva Test provides PCR results at the point of care in just 27 minutes and is robust with existing variants
Peak Proteins' expertise in protein crystallography will enhance Sygnature Discovery’s fragment screening and analysis activities as well as its structure-based drug design capabilities
The three companies will work to accelerate development of automated insulin delivery system for people living with diabetes
Antibodies against COVID-19 were found in the blood of 85% of newborn babies whose mothers tested positive for IgG antibodies against COVID-19 while pregnant
Findings suggest women with COVID-19 during pregnancy are five times more likely to be hospitalized, and six times as likely to require treatment in intensive care
Study in over 20,000 Canadian adults hospitalized with COVID-19 finds vaccination with at least one dose is linked with a significantly lower risk of ICU admission and death
Analysis of antimicrobial resistance in 271 US hospitals finds higher rates of antibiotic-resistant infections in both COVID-19 patients and SARS-COV-2 negative patients admitted during the pandemic compared to pre-pandemic
The report provides real-world treatment and outcome data for 850,000 US adults hospitalized with COVID-19 over 20 months of the pandemic
Trial results presented at ECCMID show potential of Actiphage for risk stratification in those with latent TB
Three-day in-person educational event allows attendees to network and learn in over 100 sessions focused on cannabis analytical science, medicine/wellness, cultivation, hemp and psychedelics
Blood test could be used to identify patients most likely to become severely ill before they deteriorate
The researchers were able to build a decision tree to predict COVID-19 patients at risk of a poor prognosis
Leafy greens are particularly susceptible to contamination due to their proximity to the ground and the likelihood of people eating them without cooking
Nursery children were found to be exposed to the greatest variety of pathogens and the highest concentrations compared to other groups investigated
An electronic questionnaire was used to gather information about sick leave and side effects from the 1,797 healthcare workers
The combination of technologies facilitates a fully connected laboratory with standard data integrity, data mobility, system flexibility, and user reconfigurability